Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Although reports on ethylcathinone use are relatively scarce, available information indicates patterns consistent with other substituted cathinones. Compulsive redosing appears common, with users frequently combining routes of administration—for example, alternating between oral and insufflated doses within a single session. The urge to recapture initial effects often leads to subsequent doses that exceed the starting amount or are taken in rapid succession. Many experience reports describe difficulty resisting additional doses once effects begin to diminish, with some users unintentionally consuming a gram or more in a single session. Individual responses to any given dose can vary substantially, and what produces manageable effects in one person may be dangerous for another.
Duration
Subjective Effects
Pharmacology
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Addiction & Dependence
Psychological
ModeratePsychological dependence is possible given its euphoric stimulant effects profile. Many users report difficulty not redosing after strong doses, with experience reports of unexpectedly consuming a gram or more being common. Insufflation is particularly associated with compulsive use patterns.
Physical
LowUnlikely to be physically addictive, with withdrawal symptoms expected to be minimal and not life-threatening.
Psychosis Risk
Abuse at high dosages for prolonged periods can potentially result in stimulant psychosis presenting with paranoia, hallucinations, or delusions. Approximately 5-15% of users who develop stimulant psychosis from amphetamine-class compounds fail to recover completely.
History & Culture
Legality
International
Grey-area status is reported in many jurisdictions.
By Country
References
Citations
- Resolução da Diretoria Colegiada Anvisa nº 1.036, de 09/07/2026. anvisalegis.datalegis.net (n.d.). https://anvisalegis.datalegis.net/action/ActionDatalegis.php?acao=abrirTextoAto&tipo=RDC&numeroAto=00001036&seqAto=000&valorAno=2026&orgao=RDC/DC/ANVISA/MS&codTipo=&desItem=&desItemFim=&cod_menu=1696&cod_modulo=134&pesquisa=true1
- Resolução-RDC nº 49, de 11 de novembro de 2015. gov.br (n.d.). https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista/arquivos-controlados/6560json-file-1/@@display-file/file1
- Portaria - PRT nº 344, de 12/05/1998. anvisalegis.datalegis.net (n.d.). https://anvisalegis.datalegis.net/action/ActionDatalegis.php?acao=abrirTextoAto&tipo=POR&numeroAto=00000344&seqAto=000&valorAno=1998&orgao=SVS/MS&codTipo=&desItem=&desItemFim=&cod_menu=1696&cod_modulo=134&pesquisa=true1
- Lei nº 11.343, de 23 de agosto de 2006 — texto atualizado. www2.camara.leg.br (n.d.). https://www2.camara.leg.br/legin/fed/lei/2006/lei-11343-23-agosto-2006-545399-normaatualizada-pl.html1
- Health Canada Drug Analysis Service and Cannabis Laboratory — HC DAS and CL classification framework for psychoactive substances in the illicit drug market (2026-07-06 substance list). health-infobase.canada.ca (n.d.). https://health-infobase.canada.ca/src/data/DAS/newLayout/20260706_ClassificationTable_Public.csv1
- Controlled Drugs and Substances Act, current consolidated Schedule I. laws-lois.justice.gc.ca (n.d.). https://www.laws-lois.justice.gc.ca/eng/acts/C-38.8/section-sched95314.html1
- Controlled Drugs and Substances Act, section 2 — Definitions. laws-lois.justice.gc.ca (n.d.). https://www.laws-lois.justice.gc.ca/eng/acts/C-38.8/section-2.html1
- Controlled Drugs and Substances Act, section 4 — Possession of substance. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/C-38.8/section-4.html1
- Controlled Drugs and Substances Act, section 5 — Trafficking in substance. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/C-38.8/section-5.html1
- Controlled Drugs and Substances Act, section 6 — Importing and exporting. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/C-38.8/section-6.html1
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the ETH-CAT article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.